Cargando…
Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children
BACKGROUND: Over 250 million children under 5 years, globally, are at risk of developmental delay. Interventions during the first 2 years of life have enduring positive effects if children at risk are identified, using standardized assessments, within this window. However, identifying developmental...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783969/ https://www.ncbi.nlm.nih.gov/pubmed/36564728 http://dx.doi.org/10.1186/s12887-022-03794-1 |
_version_ | 1784857700086054912 |
---|---|
author | Fernandes, Michelle Bassani, Diego Albernaz, Elaine Bertoldi, Andrea D. Silveira, Mariangela F. Matijsevich, Alicia Anselmi, Luciana Cruz, Suélen Halal, Camila S. Tovo-Rodrigues, Luciana Cruz, Gloria Isabel Nino Metgud, Deepa Santos, Ina S. |
author_facet | Fernandes, Michelle Bassani, Diego Albernaz, Elaine Bertoldi, Andrea D. Silveira, Mariangela F. Matijsevich, Alicia Anselmi, Luciana Cruz, Suélen Halal, Camila S. Tovo-Rodrigues, Luciana Cruz, Gloria Isabel Nino Metgud, Deepa Santos, Ina S. |
author_sort | Fernandes, Michelle |
collection | PubMed |
description | BACKGROUND: Over 250 million children under 5 years, globally, are at risk of developmental delay. Interventions during the first 2 years of life have enduring positive effects if children at risk are identified, using standardized assessments, within this window. However, identifying developmental delay during infancy is challenging and there are limited infant development assessments suitable for use in low- and middle-income (LMIC) settings. Here, we describe a new tool, the Oxford Neurodevelopment Assessment (OX-NDA), measuring cognition, language, motor, and behaviour, outcomes in 1-year-old children. We present the results of its evaluation against the Bayley Scales of Infant Development IIIrd edition (BSID-III) and its psychometric properties. METHODS: Sixteen international tools measuring infant development were analysed to inform the OX-NDA’s construction. Its agreement with the BSID-III, for cognitive, motor and language domains, was evaluated using intra-class correlations (ICCs, for absolute agreement), Bland-Altman analyses (for bias and limits of agreement), and sensitivity and specificity analyses (for accuracy) in 104 Brazilian children, aged 12 months (SD 8.4 days), recruited from the 2015 Pelotas Birth Cohort Study. Behaviour was not evaluated, as the BSID-III’s adaptive behaviour scale was not included in the cohort’s protocol. Cohen’s kappas and Cronbach’s alphas were calculated to determine the OX-NDA’s reliability and internal consistency respectively. RESULTS: Agreement was moderate for cognition and motor outcomes (ICCs 0.63 and 0.68, p < 0.001) and low for language outcomes (ICC 0.30, p < 0.04). Bland-Altman analysis showed little to no bias between measures across domains. The OX-NDA’s sensitivity and specificity for predicting moderate-to-severe delay on the BSID-III was 76, 73 and 43% and 75, 80 and 33% for cognition, motor and language outcomes, respectively. Inter-rater (k = 0.80-0.96) and test-rest (k = 0.85-0.94) reliability was high for all domains. Administration time was < 20 minutes. CONCLUSION: The OX-NDA shows moderate agreement with the BSID-III for identifying infants at risk of cognitive and motor delay; agreement was low for language delay. It is a rapid, low-cost assessment constructed specifically for use in LMIC populations. Further work is needed to evaluate its use (i) across domains in populations beyond Brazil and (ii) to identify language delays in Brazilian children. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-022-03794-1. |
format | Online Article Text |
id | pubmed-9783969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97839692022-12-24 Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children Fernandes, Michelle Bassani, Diego Albernaz, Elaine Bertoldi, Andrea D. Silveira, Mariangela F. Matijsevich, Alicia Anselmi, Luciana Cruz, Suélen Halal, Camila S. Tovo-Rodrigues, Luciana Cruz, Gloria Isabel Nino Metgud, Deepa Santos, Ina S. BMC Pediatr Research BACKGROUND: Over 250 million children under 5 years, globally, are at risk of developmental delay. Interventions during the first 2 years of life have enduring positive effects if children at risk are identified, using standardized assessments, within this window. However, identifying developmental delay during infancy is challenging and there are limited infant development assessments suitable for use in low- and middle-income (LMIC) settings. Here, we describe a new tool, the Oxford Neurodevelopment Assessment (OX-NDA), measuring cognition, language, motor, and behaviour, outcomes in 1-year-old children. We present the results of its evaluation against the Bayley Scales of Infant Development IIIrd edition (BSID-III) and its psychometric properties. METHODS: Sixteen international tools measuring infant development were analysed to inform the OX-NDA’s construction. Its agreement with the BSID-III, for cognitive, motor and language domains, was evaluated using intra-class correlations (ICCs, for absolute agreement), Bland-Altman analyses (for bias and limits of agreement), and sensitivity and specificity analyses (for accuracy) in 104 Brazilian children, aged 12 months (SD 8.4 days), recruited from the 2015 Pelotas Birth Cohort Study. Behaviour was not evaluated, as the BSID-III’s adaptive behaviour scale was not included in the cohort’s protocol. Cohen’s kappas and Cronbach’s alphas were calculated to determine the OX-NDA’s reliability and internal consistency respectively. RESULTS: Agreement was moderate for cognition and motor outcomes (ICCs 0.63 and 0.68, p < 0.001) and low for language outcomes (ICC 0.30, p < 0.04). Bland-Altman analysis showed little to no bias between measures across domains. The OX-NDA’s sensitivity and specificity for predicting moderate-to-severe delay on the BSID-III was 76, 73 and 43% and 75, 80 and 33% for cognition, motor and language outcomes, respectively. Inter-rater (k = 0.80-0.96) and test-rest (k = 0.85-0.94) reliability was high for all domains. Administration time was < 20 minutes. CONCLUSION: The OX-NDA shows moderate agreement with the BSID-III for identifying infants at risk of cognitive and motor delay; agreement was low for language delay. It is a rapid, low-cost assessment constructed specifically for use in LMIC populations. Further work is needed to evaluate its use (i) across domains in populations beyond Brazil and (ii) to identify language delays in Brazilian children. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-022-03794-1. BioMed Central 2022-12-23 /pmc/articles/PMC9783969/ /pubmed/36564728 http://dx.doi.org/10.1186/s12887-022-03794-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Fernandes, Michelle Bassani, Diego Albernaz, Elaine Bertoldi, Andrea D. Silveira, Mariangela F. Matijsevich, Alicia Anselmi, Luciana Cruz, Suélen Halal, Camila S. Tovo-Rodrigues, Luciana Cruz, Gloria Isabel Nino Metgud, Deepa Santos, Ina S. Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children |
title | Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children |
title_full | Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children |
title_fullStr | Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children |
title_full_unstemmed | Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children |
title_short | Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children |
title_sort | construction and validation of the oxford neurodevelopment assessment (ox-nda) in 1-year-old brazilian children |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783969/ https://www.ncbi.nlm.nih.gov/pubmed/36564728 http://dx.doi.org/10.1186/s12887-022-03794-1 |
work_keys_str_mv | AT fernandesmichelle constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren AT bassanidiego constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren AT albernazelaine constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren AT bertoldiandread constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren AT silveiramariangelaf constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren AT matijsevichalicia constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren AT anselmiluciana constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren AT cruzsuelen constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren AT halalcamilas constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren AT tovorodriguesluciana constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren AT cruzgloriaisabelnino constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren AT metguddeepa constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren AT santosinas constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren |